Parexel CEO Josef Von Rickenbach unloaded 50,000 shares of stock last Friday.
The sell-off comes as Parexel recently exceeded expectations with its second quarter results.
Analysts at Barclays raised their price target on Parexel shares from $48.00 to $52.00 in a research note from last week, while analysts at ISI Group upgraded shares of the company’s stock from a “buy” rating to a “strong-buy” rating in a research note to investors on Wednesday, January 22nd.
And analysts at Thomson Reuters/Verus downgraded shares of Parexel. One research analyst has rated the stock with a sell rating, seven have given it a hold rating, five have offered a buy rating and two have said the stock deserves a strong buy rating, according to reports.